|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2006-9-28
|
|
pubmed:abstractText |
In Zambia, unacceptably high resistance to commonly used antimalarial drugs prompted the choice of artemether-lumefantrine (AL) as first line treatment for uncomplicated Plasmodium falciparum malaria. Although the safety and efficacy of AL have been extensively documented, no clinical trials had been carried out in Zambia.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-10813475,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-11009139,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-11127248,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-11262208,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-11978332,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-14522535,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15307433,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15324470,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15486837,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15548313,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15567011,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15717281,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15850630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-15850631,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-16136476,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-16163624,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-16195289,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-8122920,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-9449273,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16923176-9657512
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1475-2875
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
73
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16923176-Adult,
pubmed-meshheading:16923176-Animals,
pubmed-meshheading:16923176-Antimalarials,
pubmed-meshheading:16923176-Artemisinins,
pubmed-meshheading:16923176-Drug Combinations,
pubmed-meshheading:16923176-Ethanolamines,
pubmed-meshheading:16923176-Fluorenes,
pubmed-meshheading:16923176-Humans,
pubmed-meshheading:16923176-Malaria, Falciparum,
pubmed-meshheading:16923176-Odds Ratio,
pubmed-meshheading:16923176-Plasmodium falciparum,
pubmed-meshheading:16923176-Pyrimethamine,
pubmed-meshheading:16923176-Sulfadoxine,
pubmed-meshheading:16923176-Zambia
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
|
|
pubmed:affiliation |
Department Parasitology, Institute of Tropical Medicine, Nationalestraat 155, B-2000 Antwerp, Belgium. clinsciences@zamtel.zm
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
